Skip to content

Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy

Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04905173
Enrollment
0
Registered
2021-05-27
Start date
2021-11-30
Completion date
2022-05-31
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathy, Hypertrophic, Hypertrophic Cardiomyopathy, Hypertrophic Obstructive Cardiomyopathy

Keywords

squat to stand maneuver, amyl nitrite, echocardiography, valsalva, exercise stress echocardiography, left ventricular outflow tract obstruction, maximal instantaneous gradient, hypertrophic cardiomyopathy, latent obstruction, dynamic obstruction, squat-to-stand

Brief summary

The purpose of this study is to assess the effectiveness of squat-to-stand maneuver in eliciting left ventricular outflow gradients in patients with Hypertrophic Cardiomyopathy (HCM) compared to Valsalva, amyl nitrite inhalation, and exercise stress echocardiogram (ESE).

Detailed description

Left ventricular hypertrophy and abnormal ventricular configuration result in dynamic left ventricular outflow obstruction in \ 75% of HCM patients, which is associated with increased cardiac morbidity and mortality. However, the dynamic nature of the gradient can make obstruction difficult to identify. Provocative maneuvers such as Valsalva maneuver, administration of amyl nitrite, and ESE are currently used to assess for obstruction. A shortage of amyl nitrite beginning in December 2018 spurred a search for alternative provocative maneuvers. Beginning in February 2019, the Mayo Clinic echocardiography laboratory began utilizing a squat-to-stand maneuver as an alternative to amyl nitrite inhalation. Anecdotally, the squat-to-stand maneuver, which decreases both preload and afterload, has been successful in provoking latent left ventricular outflow obstruction. A retrospective study (Peng et al, in progress) studying 119 patients who performed the squat-to-stand maneuver between February and September 2019 demonstrated squat-to-stand to be a more robust provocative maneuver than the Valsalva maneuver for identifying severe dynamic left ventricular obstruction with Doppler echocardiography. Squat-to-stand elicited latent obstruction in a greater proportion of the study participants and higher average gradients. It also demonstrated the potential to alter clinical management - six patients had severe obstruction only with squat-to-stand (otherwise would not have been diagnosed) and subsequently underwent septal reduction surgery. The recent return of amyl nitrite to the echocardiography laboratory creates an opportunity for direct comparison with squat-to-stand, particularly regarding cost savings and diagnostic performance. The primary purpose of this study is to evaluate the efficacy and degree of provocation of left ventricular outflow gradients by the squat-to-stand maneuver compared to amyl nitrite inhalation in patients with HCM undergoing echocardiography. Squat-to-stand will also be compared with other provocation methods, including Valsalva maneuver, which should be performed on every patient going on to squat-to-stand, and ESE when available. Validating this novel provocative maneuver can broaden the toolbox of techniques used to elicit left ventricular outflow gradients and improve clinical evaluation and management of symptomatic HCM patients.

Interventions

OTHERSquat-to-stand maneuver

Subjects will squat for 5 seconds and then stand. The squat-to-stand exercise will be done up to 10 times, and then immediately undergo echocardiographic imaging.

DRUGAmyl nitrite inhalation

Subjects will inhale amyl nitrite prior to undergoing echocardiographic imaging. This is administered according to current laboratory protocol and is part of standard of care. This is an FDA-regulated drug that will be used as a control and will not be studied experimentally.

OTHERValsalva

Subjects will undergo echocardiographic imaging while performing the Valsalva maneuver. This is according to current laboratory protocol and is part of standard of care.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥ 18 y/o referred for an outpatient echocardiogram. * Clinical diagnosis of Hypertrophic Cardiomyopathy (HCM). * Both amyl nitrite inhalation and squat-to-stand maneuver performed during echocardiogram.

Exclusion criteria

* Patients \< 18 at the time of echocardiogram. * Studies without documented provocative maneuvers. * Patients with resting obstruction (MIG \> 50 mmHg). * Patients unable to undergo the squat-to-stand as protocolled based because of physical limitations. * Patient with contraindications to amyl nitrite administration.

Design outcomes

Primary

MeasureTime frameDescription
Severe provokable obstructionBaselinePercentage of patients with provokable obstruction (rest gradient \< 30 mmHg AND gradient w/ maneuver ≥ 30 mmHg) by provocation technique

Secondary

MeasureTime frameDescription
Maximal instantaneous gradientBaselineMaximal instantaneous gradient (MIG) by provocation technique measured in mm Hg
Completion of squat-to-stand maneuverBaselinePercentage of patients unable to complete a squat-to-stand maneuver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026